Ruth Nicholson Klepfer

Ruth Nicholson Klepfer

Auto-generated profile, based on publicly available information

Ruth Nicholson Klepfer

Medtronic, plc, Mounds View, MN, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Heart Rhythm
Verified
Journal Article
Open access
AHAntonio Hernández‐Madrid
Antonio Hernández‐Madrid
DFDomenico Facchin
Domenico Facchin
RKRuth Nicholson Klepfer
Ruth Nicholson Klepfer
SGSubham Ghosh
Subham Ghosh
RMRoberto Matía
Roberto Matía
ALAlessandro Locatelli
Alessandro Locatelli
A high percentage of biventricular (BiV) or left ventricular (LV) pacing in cardiac resynchronization therapy (CRT) devices has been associated with superior clinical outcomes. However, the percent ventricular (%V) pacing reported by CRT devices simply indicates the number of paces the device has delivered and not the proportion of pacing that has captured the LV effectively. The purpose of this study was to determine whether a beat-by-beat evaluation of effective pacing would provide a more accurate evaluation of CRT delivery. An automatic electrogram (EGM)-based algorithm that classifies each LV pace as effective or ineffective based on detection of QS/QS-r morphology on the unipolar LV EGM during pacing was developed and validated. LV EGMs that were recorded by 24-hour Holter from 57 CRT patients were postprocessed. The percent effective CRT (%e-CRT) pacing was calculated by dividing the time spent in e-CRT pacing by the total time of the recording. In this CRT cohort, the average %V pacing (94.8% ± 8%) significantly overestimated the %e-CRT pacing (87.5% ± 23%; P <.001). A significant minority of subjects (18%) had a discrepancy of at least 3 percentage points between %V pacing and %e-CRT pacing (mean 39% ± 41%). Current device pacing diagnostics overestimate the amount of CRT pacing actually delivered. The new algorithm quantifies ineffective CRT pacing, which enables clinicians to identify patients with this issue and to address the reasons behind suboptimal CRT delivery.

1 June 2019 in ClinicoEconomics and Outcomes Research
Verified
Journal Article
Open access
PDF file
AHAntonio Hernández-Madrid
Antonio Hernández-Madrid
XLXiaoxiao Lu
Xiaoxiao Lu
STStelios I Tsintzos
Stelios I Tsintzos
DFDedra H Fagan
Dedra H Fagan
RKRuth Nicholson Klepfer
Ruth Nicholson Klepfer
ECEugene S Chung
Eugene S Chung
Background: The hOLter for Efficacy analysis (OLE) study demonstrated that current device pacing diagnostics overestimate the amount of cardiac resynchronization therapy (CRT) pacing that effectively stimulates the cardiac tissue. Sub-optimal pacing increases mortality, hospitalizations, and associated health-care costs. We sought to estimate the expected number of hospital admissions due to heart failure (HF) and its respective financial impact in patients with maximized effective pacing versus conventional pacing. Methods: A Markov model was developed to project HF hospitalizations and quantify the costs that could be avoided if pacing was maximally effective. OLE data were used to inform the prevalence of ineffective pacing among CRT patients and and average loss of pacing by causes. Adaptive CRT trial data quantified the reduction in underlying hospitalization risk by increasing effective pacing delivered. Survival was informed by a meta-analysis of 5 randomized clinical trials. Costs were analyzed from a US payer perspective. Results: Projected average hospitalizations totaled 4.58 over a lifetime horizon for CRT patients with conventional pacing. Maximizing effective pacing delivery was projected to avoid 1.83 HF admissions/patient over the lifetime. This equates to a savings of 40% (US$22,802) compared with conventional pacing from the Medicare perspective. In a sensitivity analysis, CRT with effective pacing was projected to provide cost savings in all scenarios. Conclusions: Maximized effective pacing leads to a lower number of HF hospitalizations, thus allowing significant cost offsets in the US setting.

1 March 2002 in JACC
Verified
Journal Article
Closed access
DDD.Curtis Deno
D.Curtis Deno
RKRuth N. Klepfer
Ruth N. Klepfer
LMLawrence J. Mulligan
Lawrence J. Mulligan